Concepedia

Author

Michael Koslowski

Charité - Universitätsmedizin BerlinORCID

Also Known As

Koslowski, M, M KOSLOWSKI, M. Koslowski, Michael Koslowski

29

Publications

1.6K

Citations

11

H-Index

21

Concepts

All Affiliations

Charité - Universitätsmedizin BerlinStanford UniversityRuhr University BochumUniversity Hospital HeidelbergCentral Institute of Mental Health
MK

About

Michael Koslowski is an author at Charité - Universitätsmedizin Berlin specializing in biological psychiatry, psychopathology, and neuroscience.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

1.3K

2

Social Sciences

6

6

1.3K

3

Neuroscience

6

6

1.3K

4

Psychiatry

6

6

1.3K

5

Neurology

2

2

97

Michael Koslowski

×

10

Publications

1.6K

Citations

10

H-Index

YearCitations

Dysfunction of ventral striatal reward prediction in schizophrenia

Georg Juckel, Florian Schlagenhauf, Michael Koslowski,

NeuroImage

2005

575

Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics

Georg Juckel, Florian Schlagenhauf, Michael Koslowski,

Psychopharmacology

2006

321

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine

Florian Schlagenhauf, Georg Juckel, Michael Koslowski,

Psychopharmacology

2007

208

Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance

Max Wolff, Ricarda Evens, Lea J. Mertens,

Frontiers in Psychiatry

2020

172

Ventral Striatal Activation during Reward Processing in Subjects with Ultra-High Risk for Schizophrenia

Georg Juckel, Eva Friedel, Michael Koslowski,

Neuropsychobiology

2012

91

Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia

Martina Ballmaier, Florian Schlagenhauf, Arthur W. Toga,

Schizophrenia Research

2008

80

Switching schizophrenia patients from typical neuroleptics to olanzapine: Effects on BOLD response during attention and working memory

Florian Schlagenhauf, Torsten Wüstenberg, Katharina Schmack,

European Neuropsychopharmacology

2008

60

Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy

Michael Koslowski, Matthew W. Johnson, Gerhard Gründer,

Current Addiction Reports

2021

36

Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) – Rationale and study design

Lea J. Mertens, Michael Koslowski, Felix Betzler,

Neuroscience Applied

2022

34

Using routine MRI data of depressed patients to predict individual responses to electroconvulsive therapy

Matti Gärtner, Elisabetta Ghisu, Ana Lucía Herrera-Meléndez,

Experimental Neurology

2020

17

Page 1